Dr. Andrea Cox, MD

• Infectious Disease Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Johns Hopkins University School Med

  Residency Hospital

• Johns Hopkins School Of Medicine

  Medical School, 1998

• SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge, 2022-05-23

• TGF-ß1-mediatedSmad3enhances PD-1 expression on antigen-specific T cells in cancer, 2016-09-28

• Evolving trends in the prevalence of hepatitis C virus antibody positivity among HIV-infected men in a community-based primary care setting, 2020-08-02

• Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment, 2023-01-10

• Monocytes Activate Natural Killer Cells via Inflammasome-induced Interleukin 18 in Response to Hepatitis C Virus Replication, 2014-03-28

• The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19, 2021-08-26

• Metabolic programs define dysfunctional immune responses in severe COVID-19 patients, 2021-02-26

• Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection, 2017-11-20

• Can broadly neutralizing monoclonal antibodies lead us to a hepatitis C virus vaccine?, 2018-04-24

• Higher Proinflammatory Cytokines Are Associated with Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients, 2022-04-01

• Immunity and Hepatitis C: A Review, 2012-12-04

• Plasma virome and the risk of blood-borne infection in persons with substance use disorder, 2021-11-25

• SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection, 2022-05-06

• High-value laboratory testing for hospitalized COVID-19 patients: a review, 2021-09-21

• Immunogenicity and cross-reactivity of a representative ancestral sequence in HCV infection, 2012-04-16

• The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design, 2015-06-19

• Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus, 2018-12-26

• Integrated cell-free DNA and cytokine analysis uncovers distinct tissue injury and immune response patterns in solid organ transplant recipients with COVID-19, 2022-01-20

• When being a bystander is not so innocent, 2014-01-23

• Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection, 2021-02-11

• Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks, 2019-02-22

• Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections, 2017-03-16

• Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries, 2022-08-19

• Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection, 2018-11-14

• B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection, 2022-01-06

• Herpes simplex virus type 1 inflammasome activation in proinflammatory human macrophages is dependent on NLRP3, ASC, and caspase-1, 2020-02-26

• Approaches, Progress, and Challenges to Hepatitis C Vaccine Development, 2019-01-01

• Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipients, 2023-05-22

• Genome wide association study of spontaneous resolution of hepatitis C virus infection, 2013-02-19

• Multi-ancestry Fine Mapping of Interferon Lambda and the Outcome of Acute Hepatitis C Virus Infection, 2020-10-28

• HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon, 2014-05-01

• Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population, 2017-12-16

• Interleukin-18 and tumor necrosis factor-aare elevated in solid organ transplant recipients with possible cytomegalovirus end-organ disease, 2021-07-16

• Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19, 2022-05-19

• Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department, 2021-10-14

• Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection, 2022-03-08

• Antibody avidity-based approach to estimate population-level incidence of hepatitis C, 2020-03-30

• Convergent antibody responses are associated with broad neutralization of hepatitis C virus, 2023-03-24

• Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus, 2023-04-25

• A Live-attenuated Listeria Vaccine (ANZ-100) and a Live-attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase 1 Studies of Safety and Immune Induction, 2011-12-06

• Admixture Analysis of Spontaneous Hepatitis C Virus Clearance in Individuals of African-Descent, 2014-03-13

• Durable SARS-CoV-2 B cell immunity after mild or severe disease, 2020-10-30

• Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-Assembly, 2021-03-03

• A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients, 2022-01-18

• Approaches, Progress, and Challenges to Hepatitis C Vaccine Development, 2018-09-27

• Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design, 2016-06-30

• Making sense of HIV innate sensing, 2013-12-12

• Rare Birds in North America: Acute Hepatitis C Cohorts, 2008-12-04